NLRP3 and bronchopulmonary dysplasia: Simvastatin could downregulate NLRP3-related pyroptosis and attenuate lung injury in hyperoxia-induced bronchopulmonary dysplasia via a KLF2-mediated mechanism (Wang et al., 2022).